NOV 28, 2017 08:45 AM PST

Stopping Inflammation Early to Prevent Blindness From Macular Degeneration

WRITTEN BY: Kara Marker

Macular degeneration is considered to be an incurable eye disease, but a new discovery from University of Virginia scientists may change that. A new study, published in Nature Medicine, identifies a specific enzyme involved in the immune response that has also surprising role in sparking inflammation that leads to blindness for the 200 million people living with macular degeneration worldwide.

Macular degeneration. Credit: Ralf Roletschek

"For the first time, we know in macular degeneration what is one of the very first events that triggers the system to get alarmed,” explained UVA’s Jayakrishna Ambati, MD. “This overdrive of inflammation is what ultimately damages cells, and so, potentially, we have a way of interfering very early in the process."

Macular degeneration, more than glaucoma and cataracts combined, is the leading cause of blindness among the elderly. It is caused by the deterioration of the central portion of the retina, called the macula, which provides vision we use to read, drive, and recognize faces.

A large majority of macular degeneration cases are of the “dry” type, which means that small deposits that form on the retina are responsible for deterioration. However, 10-15 percent of cases are the “wet” type, which means that deterioration occurs more quickly and more severely. Deterioration in cases of wet macular degeneration is caused by abnormal blood vessels that grow under the retina and toward the macula, which tend to break, bleed, and leak fluid. Little is known about what causes macular degeneration other than that it is a mix between genetics and environment.

However, the newest discovery of the involvement of an enzyme called cGAS provides an exciting opportunity for medical intervention: reducing inflammation to prevent blindness.

Past studies recorded the role of cGAS in the immune response to infections - the enzyme detects foreign DNA. But when scientists recently discovered that cGAS also plays a part in dry macular degeneration, they were surprised, because no research has ever suggested that macular degeneration is connected to invading bacteria or viruses.

Nonetheless, cGAS is indeed activated during the development of this form of the disease, and its activation alerts the immune system and results in retinal cell death and, ultimately, vision loss. These findings suggest that cGAS might also be potentially connected to other diseases related to the immune system, including diabetes, lupus, and obesity.

With cGAS identified as a target for treating macular degeneration, the clear next step is to drug development based on stopping cGAS from functioning in the context of macular degeneration, but the process will take several years to complete, as comprehensive tests for safety and efficacy are needed. Researchers are also interested in designing clinical tests to measure cGAS levels in the eyes of patients with macular degeneration, to help identify most at-risk candidates for a potential cGAS-inhibiting drug.

"Because the target we're talking about is an enzyme, we could develop small molecules that could block it," explained Nagaraj Kerur, PhD. "There are many drugs already on the market that target specific enzymes.”

Sources: American Foundation for the Blind, American Macular Degeneration Foundation, University of Virginia Health System

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 25, 2018
Immunology
JUL 25, 2018
T Cell Response to Ebola Virus Proteins
Killer T cells of Ebola survivors respond better to nucleoproteins, not glycoproteins, potentially influencing Ebola vaccine development....
AUG 21, 2018
Immunology
AUG 21, 2018
T cells Trapped by Brain Cancer
Brain tumors prevent T cells from escaping the bone marrow by altering levels of the S1P1 protein....
AUG 22, 2018
Immunology
AUG 22, 2018
Immune Response Runs on the Body Clock
Immune cell functions such as inflammation are dictated by your bodies circadian rhythm, responding daily to external stimuli on a 24 hour schedule....
AUG 25, 2018
Immunology
AUG 25, 2018
Maternal Depression Alters Mom and Baby's Immune Markers
Maternal depression alters stress and immune system biomarkers in children leading to social withdrawal and behavioral problems....
SEP 11, 2018
Immunology
SEP 11, 2018
Oops! I Broke My DNA
Innate Immune System, DNA Damage and Repair...
OCT 10, 2018
Microbiology
OCT 10, 2018
It's Time for Your Annual Flu Shot
After last year's flu season killed around 80,000 people, the CDC is trying to get the word out about the flu vaccine....
Loading Comments...